Area of research
Molecular Biology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Epigenetics and DNA Methylation, Cancer-related gene regulation, RNA modifications and cancer, and Lung Cancer Diagnosis and Treatment.
Targeting inosine metabolism to enhance EGFR-targeted therapy in lung adenocarcinoma
Abstract CT126: Aumolertinib as adjuvant therapy in patients with stage II-IIIB EGFR-mutated NSCLC after complete tumor resection: A randomized, double-blind, placebo-controlled, phase 3 trial (ARTS)
UPP1 promotes lung adenocarcinoma progression through the induction of an immunosuppressive microenvironment
Perioperative outcomes and survival after neoadjuvant immunochemotherapy for locally advanced esophageal squamous cell carcinoma
Pulmonary delivery of dual-targeted nanoparticles improves tumor accumulation and cancer cell targeting by restricting macrophage interception in orthotopic lung tumors
FGL1 in plasma extracellular vesicles is correlated with clinical stage of lung adenocarcinoma and anti-PD-L1 response
BIRC5 Modulates PD-L1 Expression and Immune Infiltration in Lung Adenocarcinoma
International expert consensus on immunotherapy for early-stage non-small cell lung cancer
The SMART App: an interactive web application for comprehensive DNA methylation analysis and visualization
A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies
Clinical guidelines on perioperative management strategies for enhanced recovery after lung surgery
Two plasma microRNA panels for diagnosis and subtype discrimination of lung cancer
Ubiquitin-protein ligase E3C maintains non-small-cell lung cancer stemness by targeting AHNAK-p53 complex
Preoperative 3-dimensional computed tomography lung simulation before video-assisted thoracoscopic anatomic segmentectomy for ground glass opacity in lung
CXCL5 regulation of proliferation and migration in human non-small cell lung cancer cells
Low level of 5-Hydroxymethylcytosine predicts poor prognosis in non-small cell lung cancer
A new microRNA signal pathway regulated by long noncoding RNA TGFB2-OT1 in autophagy and inflammation of vascular endothelial cells
Identification of a novel MTOR activator and discovery of a competing endogenous RNA regulating autophagy in vascular endothelial cells
DNMT1–MicroRNA126 Epigenetic Circuit Contributes to Esophageal Squamous Cell Carcinoma Growth via ADAM9–EGFR–AKT Signaling
USP7 overexpression predicts a poor prognosis in lung squamous cell carcinoma and large cell carcinoma
MicroRNA-7 sensitizes non-small cell lung cancer cells to paclitaxel
FoxM1 Is Associated with Poor Prognosis of Non-Small Cell Lung Cancer Patients through Promoting Tumor Metastasis
Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer
The overexpression of 14‐3‐3ζ and Hsp27 promotes non–small cell lung cancer progression
Prognostic significance of the IASLC/ATS/ERS classification in Chinese patients—A single institution retrospective study of 292 lung adenocarcinoma
Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models